Phosphorylated KIT as a predictor of outcome in canine mast cell tumours treated with toceranib phosphate or vinblastine

• DOI: 10.1111/vco.12525
• Publication Date: 2019-07-31T12:54:26Z
• Authors: Douglas H. Thamm; Kristen M. Weishaar; Joseph B. Charles; E. J. Ehrhart
• Keywords: 0301 basic medicine; Indoles; Skin Neoplasms; Mast-Cell Sarcoma; Antineoplastic Agents; 04 agricultural and veterinary sciences; Vinblastine; 3. Good health; Gene Expression Regulation, Neoplastic; 0403 veterinary science; Proto-Oncogene Proteins c-kit; 03 medical and health sciences; Dogs; Animals; Pyrroles; Dog Diseases; Prospective Studies; Phosphorylation

AbstractCanine cutaneous mast cell tumour (MCT) is the most common malignant skin tumour in dogs and can exhibit variable biologic behaviour. Dysregulated signalling through the receptor tyrosine kinase (RTK) KIT can promote cell proliferation and survival, and assessment of its dysregulation via detection of activating c‐kit gene mutations or assessment of KIT protein localization is associated with multiple features of malignancy. The aim of the current study was to use a previously validated immunohistochemical (IHC) assay to directly measure phosphorylated KIT (pKIT) in order to investigate its association with other established prognostic markers, response to therapy, progression free interval (PFI) and overall survival time (OST) in dogs treated medically for measurable MCT. Tumour tissue from 74 dogs enrolled in a prospective study comparing toceranib and vinblastine for MCT treatment were evaluated for pKIT immunoreactivity. pKIT was variably expressed, with some degree of positivity observed in 49/74 cases (66%). pKIT immunoreactivity was significantly associated with aberrant KIT localization, high mitotic index and high histologic grade. On univariate analysis, pKIT immunoreactivity predicted shorter PFI and OST in the entire patient population as well as shorter PFI in the toceranib treated group, and was the sole predictive factor for OST upon multivariate analysis, while mitotic index was the sole independent predictive factor for PFI. These results demonstrate that IHC detection of pKIT correlates with several features of aggressive behaviour, and may confer information that is complementary to other prognostic factors. However, the role of pKIT in predicting outcome needs to be studied further before recommendations can be made for its routine use.